Jag Capital Management, LLC Astrazeneca PLC Transaction History

Jag Capital Management, LLC

$821 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$64.85 - $71.7 $6,549 - $7,241	-101 Reduced 0.34%	29,203 $1.98 Million
Q2 2023 Sep 07, 2023	BUY	$69.91 - $75.81 $92,630 - $100,448	1,325 Added 4.74%	29,304 $2.1 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $92,630 - $100,448	1,325 Added 4.74%	29,304 $2.1 Million
Q1 2023 Sep 07, 2023	BUY	$63.15 - $71.6 $883,784 - $1 Million	13,995 Added 100.08%	27,979 $1.94 Million
Q1 2023 Sep 01, 2023	BUY	$63.15 - $71.6 $883,784 - $1 Million	13,995 Added 100.08%	27,979 $1.94 Million
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $773,903 - $877,457	12,255 Added 77.94%	27,979 $1.94 Million
Q4 2022 Sep 07, 2023	SELL	$54.21 - $70.44 $830,497 - $1.08 Million	-15,320 Reduced 52.28%	13,984 $948,000
Q4 2022 Sep 01, 2023	SELL	$54.21 - $70.44 $830,497 - $1.08 Million	-15,320 Reduced 52.28%	13,984 $948,000
Q4 2022 Feb 08, 2023	BUY	$54.21 - $70.44 $518,518 - $673,758	9,565 Added 155.3%	15,724 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $19,193 - $49,141	-362 Reduced 5.55%	6,159 $338,000
Q2 2022 Aug 01, 2022	SELL	$59.26 - $71.14 $23,289 - $27,958	-393 Reduced 5.68%	6,521 $431,000
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $36,663 - $44,164	658 Added 10.52%	6,914 $344,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $1,080 - $1,276	-20 Reduced 0.32%	6,256 $364,000
Q3 2021 Oct 21, 2021	SELL	$55.56 - $60.79 $36,891 - $40,364	-664 Reduced 9.57%	6,276 $377,000
Q2 2021 Jul 23, 2021	BUY	$48.42 - $60.18 $1,258 - $1,564	26 Added 0.38%	6,940 $416,000
Q1 2021 Apr 23, 2021	BUY	$47.16 - $54.44 $282 - $326	6 Added 0.09%	6,914 $344,000
Q4 2020 Feb 01, 2021	BUY	$48.52 - $58.02 $22,125 - $26,457	456 Added 7.07%	6,908 $345,000
Q3 2020 Oct 21, 2020	BUY	$53.07 - $61.1 $159 - $183	3 Added 0.05%	6,452 $354,000
Q2 2020 Jul 23, 2020	SELL	$43.1 - $55.31 $2,542 - $3,263	-59 Reduced 0.91%	6,449 $341,000
Q1 2020 Apr 16, 2020	SELL	$37.79 - $51.33 $60,086 - $81,614	-1,590 Reduced 19.63%	6,508 $291,000
Q4 2019 Jan 27, 2020	BUY	$42.46 - $50.46 $20,041 - $23,817	472 Added 6.19%	8,098 $404,000
Q3 2019 Oct 24, 2019	SELL	$40.12 - $45.47 $1,644 - $1,864	-41 Reduced 0.53%	7,626 $340,000
Q2 2019 Jul 22, 2019	BUY	$37.28 - $41.68 $285,825 - $319,560	7,667 New	7,667 $317,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jag Capital Management, LLC with notifications on news.

Account